Cargando…

Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment

The tumor is an uncontrolled growth of tissue that can be localized (benign) or possesses the capability of metastasis (malignant). The conventional methods of tumor diagnosis, such as acupuncture, endoscopy, and histopathology, and treatment methods, such as injections, chemotherapy, surgery, and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Vaibhavi Meghraj, Priya, Sakshi, Gorantla, Srividya, Singhvi, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866211/
https://www.ncbi.nlm.nih.gov/pubmed/36678643
http://dx.doi.org/10.3390/pharmaceutics15010014
_version_ 1784876033267204096
author Desai, Vaibhavi Meghraj
Priya, Sakshi
Gorantla, Srividya
Singhvi, Gautam
author_facet Desai, Vaibhavi Meghraj
Priya, Sakshi
Gorantla, Srividya
Singhvi, Gautam
author_sort Desai, Vaibhavi Meghraj
collection PubMed
description The tumor is an uncontrolled growth of tissue that can be localized (benign) or possesses the capability of metastasis (malignant). The conventional methods of tumor diagnosis, such as acupuncture, endoscopy, and histopathology, and treatment methods, such as injections, chemotherapy, surgery, and radiotherapy, are invasive, expensive, and pose severe safety and management issues for the patients. Microneedle technology is a recently developed approach for active transdermal drug delivery. It is minimally invasive, self-administrable, bypasses the first-pass effect, and effectively delivers chemotherapeutics and drugs at low doses, thus, overcoming the drawbacks of conventional delivery systems. This review provides an idea of the types, materials utilized in the fabrication, and techniques used for the preparation of microneedles (MNs), as well as their application in tumor diagnosis and treatment. Additionally, emphasis is given to the case studies related to MNs-assisted tumor therapy, such as photothermal therapy, gene therapy, photodynamic therapy, chemotherapy, immunotherapy, and various combination therapies. MNs also serve as a tool for diagnosis by the bio-sampling of blood and interstitial skin fluid, as well as biosensing various cancer biomarkers. The combined therapy and diagnostics provide theranostic MNs for enhanced and personalized tumor therapy. The limitations and prospects of MNs development are also discussed.
format Online
Article
Text
id pubmed-9866211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98662112023-01-22 Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment Desai, Vaibhavi Meghraj Priya, Sakshi Gorantla, Srividya Singhvi, Gautam Pharmaceutics Review The tumor is an uncontrolled growth of tissue that can be localized (benign) or possesses the capability of metastasis (malignant). The conventional methods of tumor diagnosis, such as acupuncture, endoscopy, and histopathology, and treatment methods, such as injections, chemotherapy, surgery, and radiotherapy, are invasive, expensive, and pose severe safety and management issues for the patients. Microneedle technology is a recently developed approach for active transdermal drug delivery. It is minimally invasive, self-administrable, bypasses the first-pass effect, and effectively delivers chemotherapeutics and drugs at low doses, thus, overcoming the drawbacks of conventional delivery systems. This review provides an idea of the types, materials utilized in the fabrication, and techniques used for the preparation of microneedles (MNs), as well as their application in tumor diagnosis and treatment. Additionally, emphasis is given to the case studies related to MNs-assisted tumor therapy, such as photothermal therapy, gene therapy, photodynamic therapy, chemotherapy, immunotherapy, and various combination therapies. MNs also serve as a tool for diagnosis by the bio-sampling of blood and interstitial skin fluid, as well as biosensing various cancer biomarkers. The combined therapy and diagnostics provide theranostic MNs for enhanced and personalized tumor therapy. The limitations and prospects of MNs development are also discussed. MDPI 2022-12-21 /pmc/articles/PMC9866211/ /pubmed/36678643 http://dx.doi.org/10.3390/pharmaceutics15010014 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Desai, Vaibhavi Meghraj
Priya, Sakshi
Gorantla, Srividya
Singhvi, Gautam
Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title_full Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title_fullStr Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title_full_unstemmed Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title_short Revolutionizing Therapeutic Delivery with Microneedle Technology for Tumor Treatment
title_sort revolutionizing therapeutic delivery with microneedle technology for tumor treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866211/
https://www.ncbi.nlm.nih.gov/pubmed/36678643
http://dx.doi.org/10.3390/pharmaceutics15010014
work_keys_str_mv AT desaivaibhavimeghraj revolutionizingtherapeuticdeliverywithmicroneedletechnologyfortumortreatment
AT priyasakshi revolutionizingtherapeuticdeliverywithmicroneedletechnologyfortumortreatment
AT gorantlasrividya revolutionizingtherapeuticdeliverywithmicroneedletechnologyfortumortreatment
AT singhvigautam revolutionizingtherapeuticdeliverywithmicroneedletechnologyfortumortreatment